Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Formica Capital in connection with its acquisition of the Rototec Group, the biggest supplier of geoenergy solutions in Europe
Mandate

Vinge advises Formica Capital in connection with its acquisition of the Rototec Group, the biggest supplier of geoenergy solutions in Europe

November 25, 2021 M&A Banking and Finance

Vinge has advised Formica Capital in connection with its acquisition of all shares in the Rototec Group. Rototec is a market leader in the field of geoenergy solutions for medium and large sized properties and handles Europe’s largest fleet of drilling equipment for geoenergy issues in Finland, Sweden and Norway.

Vinge’s team mainly consisted of Magnus Pauli (M&A), Johanna Hamrefält (Project Manager, M&A), Alexander Lindeberg (IP), Adam Loewenstein (M&A), Malin Olsson (HR), Hanna Marberg (M&A) as well as Fabian Ekeblad (Banking & Finance) and Elin Samara (Banking & Finance). Krogerus Attorneys acted as local counsel in Finland with Advokatfirmaet Thommessen AS acting as local counsel in Norway.

Related

Vinge advises Intera Partners’ portfolio company Yellow Elk in connection with its acquisition of Bizware

 Vinge has advised the Nordic private equity firm Intera Partners’ portfolio company Yellow Elk in connection with its acquisition of the data analytics and AI firm Bizware AB and its subsidiaries Bizware Lead AB and Bizware Nova AB.
September 11, 2025

Vinge has acted as local counsel supporting lead counsel Latham & Watkins in advising Cadence in connection with its acquisition of Hexagon’s Design & Engineering Business for approx. EUR 2.7 billion

 Cadence (Nasdaq: CDNS) announced it has entered into a definitive agreement to acquire the Design & Engineering business of Hexagon AB, which includes its MSC Software business—a pioneer in engineering simulation and analysis solutions.
September 09, 2025

Vinge has advised Oncopeptides in connection with its rights issue

 Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025